Complementary genomic screens identify SERCA as a therapeutic target in NOTCH1 mutated cancer.
Roti G, Carlton A, Ross KN, Markstein M, Pajcini K, Su AH, Perrimon N, Pear WS, Kung AL, Blacklow SC, Aster JC, Stegmaier K.
Roti G, et al. Among authors: perrimon n.
Cancer Cell. 2013 Mar 18;23(3):390-405. doi: 10.1016/j.ccr.2013.01.015. Epub 2013 Feb 21.
Cancer Cell. 2013.
PMID: 23434461
Free PMC article.